Clinical features and mechanistic insights into drug repurposing for combating COVID-19.
Ontology highlight
ABSTRACT: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged from Wuhan in China before it spread to the entire globe. It causes coronavirus disease of 2019 (COVID-19) where mostly individuals present mild symptoms, some remain asymptomatic and some show severe lung inflammation and pneumonia in the host through the induction of a marked inflammatory 'cytokine storm'. New and efficacious vaccines have been developed and put into clinical practice in record time, however, there is a still a need for effective treatments for those who are not vaccinated or remain susceptible to emerging SARS-CoV-2 variant strains. Despite this, effective therapeutic interventions against COVID-19 remain elusive. Here, we have reviewed potential drugs for COVID-19 classified on the basis of their mode
SUBMITTER: Asrani P
PROVIDER: S-EPMC8570392 | biostudies-literature | 2022 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA